The Rapidly Acting Antidepressant Ketamine and the mGlu2/3 Receptor Antagonist LY341495 Rapidly Engage Dopaminergic Mood Circuits von Witkin, J.M., Monn, J.A., Schoepp, D.D., Li, X., Overshiner, C., Mitchell, S.N., Carter, G., Johnson, B., Rasmussen, K., Rorick-Kehn, L.M.

Volltext

Pharmacological agents acting at subtypes of metabotropic glutamate receptors von Schoepp, Darryle D., Jane, David E., Monn, James A.

Volltext

Preclinical predictors that the orthosteric mGlu2/3 receptor antagonist LY3020371 will not engender ketamine-associated neurotoxic, motor, cognitive, subjective, or abuse-liability... von Witkin, J M, Monn, J A, Li, J, Johnson, B, McKinzie, D L, Wang, X-S, Heinz, B A, Li, R, Ornstein, P L, Smith, S C, Mitch, C H, Calligaro, D O, Swanson, S, Allen, D, Phillips, K, Gilmour, G

Volltext

Attenuation of specific PCP-evoked behaviors by the potent mGlu2/3 receptor agonist, LY379268 and comparison with the atypical antipsychotic, clozapine von CARTMELL, J, MONN, J. A, SCHOEPP, D. D

Volltext

Comparative Effects of LY3020371, a Potent and Selective Metabotropic Glutamate (mGlu) 2/3 Receptor Antagonist, and Ketamine, a Noncompetitive N -Methyl-d-Aspartate Receptor Antago... von Witkin, J M, Mitchell, S N, Wafford, K A, Carter, G, Gilmour, G, Li, J, Eastwood, B J, Overshiner, C, Li, X, Rorick-Kehn, L, Rasmussen, K, Anderson, W H, Nikolayev, A, Tolstikov, V V, Kuo, M-S, Catlow, J T, Li, R, Smith, S C, Mitch, C H, Ornstein, P L, Swanson, S, Monn, J A

Volltext

LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptors von SCHOEPP, D. D, JOHNSON, B. G, MONN, J. A, WRIGHT, R. A, SALHOFF, C. R, MAYNE, N. G, WU, S, COCKERHAM, S. L, BURNETT, J. P, BELEGAJE, R, BLEAKMAN, D

Volltext

The bacterial quorum sensing molecule, 2-heptyl-3-hydroxy-4-quinolone (PQS), inhibits signal transduction mechanisms in brain tissue and is behaviorally active in mice von Di Menna, L., Busceti, C.L., Ginerete, R.P., D’Errico, G., Orlando, R., Alborghetti, M., Bruno, V., Battaglia, G., Fornai, F., Leoni, L., Rampioni, G., Visca, P., Monn, J.A., Nicoletti, F.

Volltext

Design, Synthesis, and Pharmacological Characterization of (+)-2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic Acid (LY354740):  A Potent, Selective, and Orally Active Group 2 Metabot... von Monn, James A, Valli, Matthew J, Massey, Steven M, Wright, Rebecca A, Salhoff, Craig R, Johnson, Bryan G, Howe, Trevor, Alt, Charles A, Rhodes, Gary A, Robey, Roger L, Griffey, Kelly R, Tizzano, Joseph P, Kallman, Mary J, Helton, David R, Schoepp, Darryle D

Volltext

In vivo inhibition of veratridine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740 in rats von Battaglia, Giuseppe, Monn, James A, Schoepp, Darryle D

Volltext

Systemic pre‐treatment with a group II mGlu agonist, LY379268, reduces hyperalgesia in vivo von Sharpe, E F, Kingston, A E, Lodge, D, Monn, J A, Headley, P M

Volltext

LY354740: a metabotropic glutamate receptor agonist which ameliorates symptoms of nicotine withdrawal in rats von Helton, D.R., Tizzano, J.P., Monn, J.A., Schoepp, D.D., Kallman, M.J.

Volltext

Metabotropic glutamate receptors as novel targets for anxiety and stress disorders von Schoepp, Darryle D, Swanson, Chad J, Bures, Mark, Johnson, Michael P, Linden, Anni-Maija, Monn, James A

Volltext

The Potent, Selective mGlu2/3 Receptor Agonist LY379268 Increases Extracellular Levels of Dopamine, 3,4‐Dihydroxyphenylacetic Acid, Homovanillic Acid, and 5‐Hydroxyindole‐3‐Acetic... von Cartmell, Jayne, Perry, Kenneth W., Salhoff, Craig R., Monn, James A., Schoepp, Darryle D.

Volltext

Inhibition of Cyclic AMP Formation by a Selective Metabotropic Glutamate Receptor Agonist von Schoepp, Darryle D., Johnson, Bryan G., Monn, James A.

Volltext

Neuroprotective effects of a systemically active Group II metabotropic glutamate receptor agonist LY354740 in a gerbil model of global ischaemia von Bond, Ann, OʼNeill, Michael J, Hicks, Caroline A, Monn, James A, Lodge, David

Volltext

LY379268, a potent and selective Group II metabotropic glutamate receptor agonist, is neuroprotective in gerbil global, but not focal, cerebral ischaemia von Bond, Ann, Ragumoorthy, Nella, Monn, James A., Hicks, Caroline A., Ward, Mark A., Lodge, David, O'Neill, Michael J.

Volltext

The novel metabotropic glutamate receptor agonist 2R,4R-APDC potentiates stimulation of phosphoinositide hydrolysis in the rat hippocampus by 3,5-dihydroxyphenylglycine : Evidence... von SCHOEPP, D. D, SALHOFF, C. R, WRIGHT, R. A, JOHNSON, B. G, BURNETT, J. P, MAYNE, N. G, BELAGAJE, R, WU, S, MONN, J. A

Volltext

Neuroprotective Actions of Novel and Potent Ligands of Group I and Group II Metabotropic Glutamate Receptors von KINGSTON, A. E., O'NEILL, M. J., BOND, A., BRUNO, V., BATTAGLIA, G., NICOLETTI, F., HARRIS, J. R., CLARK, B. P., MONN, J. A., LODGE, D., SCHOEPP, D. D.

Volltext

Effects of the selective metabotropic glutamate agonist LY354740 in a rat model of permanent ischaemia von Lam, Amy G.M, Soriano, Marc A, Monn, James A, Schoepp, Darryle D, Lodge, David, McCulloch, James

Volltext

A novel orally active Group 2 metabotropic glutamate receptor agonist: LY354740 von Bond, Ann, Monn, James A, Lodge, David

Volltext